CTIF Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-57423
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Synthetic peptides corresponding to KIAA0427(KIAA0427) The peptide sequence was selected from the N terminal of KIAA0427.
Peptide sequence QVQGLLADKTEGDGESERTQSHISQWTADCSEPLDSSCSFSRGRAPPQQN. The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for CTIF Antibody
![Western Blot: CTIF Antibody [NBP1-57423]](https://resources.bio-techne.com/images/products/CTIF-Antibody-Western-Blot-NBP1-57423-img0002.jpg "Western Blot: CTIF Antibody [NBP1-57423]")
Western Blot: CTIF Antibody [NBP1-57423]
Western Blot: CTIF Antibody [NBP1-57423] - HepG2 cell lysate, concentration 0.2-1 ug/ml.Applications for CTIF Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CTIF
Alternate Names
CBP80/20-dependent translation initiation factor, KIAA0427Gm672
Gene Symbol
CTIF
UniProt
Additional CTIF Products
Product Documents for CTIF Antibody
Product Specific Notices for CTIF Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...